Cite
HARVARD Citation
Palma, D. et al. (2017). Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC). Radiation oncology. 12 (1), pp. 1-4. [Online].